Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm

C Wang, X Zhu, W Feng, Y Yu, K Jeong… - American journal of …, 2015 - pmc.ncbi.nlm.nih.gov
Yes-associated protein (YAP), the central mediator of Hippo pathway, not only regulates a
diversity of cellular processes during development but also plays a pivotal role in …

Structure, function, involvement in diseases and targeting of 14-3-3 proteins: an update

Y Cau, D Valensin, M Mori, S Draghi… - Current medicinal …, 2018 - ingentaconnect.com
14-3-3 is a class of proteins able to interact with a multitude of targets by establishing protein-
protein interactions (PPIs). They are usually found in all eukaryotes with a conserved …

14-3-3σ and its modulators in cancer

G Aljabal, BK Yap - Pharmaceuticals, 2020 - mdpi.com
14-3-3σ is an acidic homodimer protein with more than one hundred different protein
partners associated with oncogenic signaling and cell cycle regulation. This review aims to …

Non-catalytic allostery in α-TAT1 by a phospho-switch drives dynamic microtubule acetylation

A Deb Roy, EG Gross, GS Pillai, S Seetharaman… - Journal of Cell …, 2022 - rupress.org
Spatiotemporally dynamic microtubule acetylation underlies diverse physiological and
pathological events. Despite its ubiquity, the molecular mechanisms that regulate the sole …

Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition

O Flores, Z Wang, KE Knudsen, KL Burnstein - Endocrinology, 2010 - academic.oup.com
1, 25-Dihydroxyvitamin D3 (1, 25-(OH) 2D3), inhibits proliferation of a variety of cell types
including adenocarcinoma of the prostate. We have previously shown that 1, 25-(OH) 2D3 …

Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein–protein interactions able to drive sensitive and Imatinib-resistant leukemia …

V Corradi, M Mancini, F Manetti, S Petta… - Bioorganic & medicinal …, 2010 - Elsevier
An in silico structure-based ligand design approach resulted in the identification of the first
non-peptidic small molecule able to inhibit protein–protein interactions between 14-3-3 and …

Computational techniques are valuable tools for the discovery of protein–protein interaction inhibitors: the 14-3-3σ case

V Corradi, M Mancini, MA Santucci… - Bioorganic & medicinal …, 2011 - Elsevier
Targeting the binding site of 14-3-3 proteins lets the release of partner proteins involved in
cell cycle progression, apoptosis, cytoskeletal rearrangement and transcriptional regulation …

Single-Cell Plasmonic Immunosandwich Assay Reveals the Modulation of Nucleocytoplasmic Localization Fluctuation of ABL1 on Cell Migration

G Ge, Y Wen, P Li, Z Guo, Z Liu - Analytical Chemistry, 2023 - ACS Publications
Cell migration is an essential process of cancer metastasis. The spatiotemporal dynamics of
signaling molecules influences cellular phenotypic outcomes. It has been increasingly …

Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells

DK Mohammad, BF Nore, A Hussain… - … and cellular biology, 2013 - Taylor & Francis
Bruton's tyrosine kinase (Btk) is crucial for B-lymphocyte activation and development.
Mutations in the Btk gene cause X-linked agammaglobulinemia (XLA) in humans and X …

Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling

R Li, X Yan, W Zhong, J Zheng, X Li, J Liang, Z Hu… - Cancer Letters, 2024 - Elsevier
Hepatocellular carcinoma (HCC) is a highly aggressive malignant tumor with limited
treatment options and poor prognosis. In this study, we reveal the pivotal role of Stratifin …